A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A
Clinical trial NCT02615691 · COMPLETED
Trial details
- NCT number
- NCT02615691
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-12
- Primary completion
- 2024-10-29
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.